WO2001068894A1 - Process for the fermentative preparation of l-amino acids with amplification of the tkt gene - Google Patents
Process for the fermentative preparation of l-amino acids with amplification of the tkt gene Download PDFInfo
- Publication number
- WO2001068894A1 WO2001068894A1 PCT/EP2000/006305 EP0006305W WO0168894A1 WO 2001068894 A1 WO2001068894 A1 WO 2001068894A1 EP 0006305 W EP0006305 W EP 0006305W WO 0168894 A1 WO0168894 A1 WO 0168894A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- codes
- lysine
- bacteria
- plasmid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1022—Transferases (2.) transferring aldehyde or ketonic groups (2.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
Definitions
- the invention relates to a process for the fermentative preparation of L-lysine, L-threonine and L-isoleucine using coryneform bacteria in which at least the tkt gene is amplified.
- L-Lysine, L-threonine and L-isoleucine are used in animal nutrition, in human medicine and in the pharmaceuticals industry.
- Methods of mutagenesis, selection and mutant .selection are used to improve the output properties of these microorganisms.
- Strains which are resistant to antimetabolites such as e. g. the threonine analogue ⁇ - amino- ⁇ -hydroxyvaleric acid (AHV) , or are auxotrophic for metabolites of regulatory importance and produce L-amino acids such as e. g. threonine are obtained in this manner.
- the inventors had the object of providing new fundamentals for improved processes for the fermentative preparation of L-lysine, L-threonine and L-isoleucine with coryneform bacteria.
- L-Lysine, L-threonine and L-isoleucine are used in human medicine and in the pharmaceuticals industry, in the foodstuffs industry and especially in animal nutrition. There is therefore a general interest in providing new improved processes for the preparation of these amino acids.
- L-amino acids are mentioned below, this means L- lysine, L-threonine and L-isoleucine.
- the invention provides a process for the fermentative preparation of L-amino acids using coryneform bacteria in which the nucleotide sequence which codes for the enzyme transketolase (EC number 2.2.1.1) (tkt gene) is amplified, in particular over-expressed.
- strains employed preferably already produce L-amino acids before amplification of the tkt gene.
- amplification in this connection describes the increase in the intracellular activity of one or more enzymes in a microorganism which are coded by the corresponding DNA, for example by increasing the number of copies of the gene or genes, using a potent promoter or using a gene which codes for a corresponding enzyme having a high activity, and optionally combining these measures.
- the microorganisms which the present invention provides can prepare L-amino acids from glucose, sucrose, lactose, fructose, maltose, molasses, starch, cellulose or from glycerol and ethanol. They are representatives of coryneform bacteria, in particular of the genus Corynebacterium. Of the genus Corynebacterium, there may be mentioned in particular the species Corynebacterium glutamicum, which is known among specialists for its ability to produce L-amino acids.
- Suitable strains of the genus Corynebacterium, in particular of the species Corynebacterium glutamicum, are, for example, the known wild-type strains
- coryneform bacteria produce L-amino acids in an improved manner after over-expression of the tkt gene, which codes for transketolase (EC number 2.2.1.1) .
- the nucleotide sequence of the tkt gene is disclosed under accession number AB023377 in the databank of the European Molecular Biology Laboratories (EMBL, Heidelberg, Germany) . Ikeda et al. (Applied Microbiology and Biotechnology 51, 201-206 (1999) furthermore describe the effect of amplification of the tkt gene on the formation of L- tryptophan, L-tyrosine and L-phenylalanine.
- the tkt gene described in the text references mentioned can be used according to the invention. Alleles of the tkt gene which result from the degeneracy of the genetic code or due to sense mutations of neutral function can furthermore be used.
- amplification e. g. over-expression
- the number of copies of the corresponding genes is increased, or the promoter and regulation region or the ribosome binding site upstream of the structural gene is mutated.
- Expression cassettes which are incorporated upstream of the structural gene act in the same way.
- inducible promoters it is additionally possible to increase the expression in the course of fermentative L- amino acid formation.
- the expression is likewise improved by measures to prolong the life of the m-RNA.
- the enzyme activity is also increased by preventing the degradation of the enzyme protein.
- the genes or gene constructs are either present here in plasmids with a varying number of copies, or are integrated and amplified in the chromosome.
- an over-expression of the genes in question can furthermore be achieved by changing the composition of the media and the culture procedure.
- transketolase was over-expressed with the aid of a plasmid.
- the E. coli - C. glutamicum shuttle vector pEC-Tl8mob2 shown in Figure 1 was used for this.
- the plasmid pMS82B shown in Figure 3 was formed.
- plasmid vectors which are capable of replication in C. glutamicum, such as e.g. pEKExl (Eikmanns et al., Gene 102:93-98 (1991)) or pZ8-l (EP-B- 0 375 889), can be used in the same way.
- L-amino acids may be advantageous for the production of L-amino acids to amplify one or more enzymes of the particular biosynthesis pathway, of glycolysis, of anaplerosis or of amino acid export, in addition to amplification of the tkt gene, which codes for transketolase .
- L- a ino acids can be amplified, preferably over-expressed, at the same time. It may furthermore be advantageous for the production of L- a ino acids at the same time to attenuate one or more of the genes chosen from the group consisting of:
- transketolase In addition to over-expression of transketolase, it may furthermore be advantageous for the production of L-amino acids to eliminate undesirable side reactions (Nakayama: “Breeding of Amino Acid Producing Micro-organisms", in: Overproduction of Microbial Products, Krumphanzl, Sikyta, Vanek (eds.), Academic Press, London, UK, 1982).
- the microorganisms prepared according to the invention can be cultured continuously or discontinuously in the batch process (batch culture) or in the fed batch (feed process) or repeated fed batch process (repetitive feed process) for the purpose of L-amino acid production.
- batch culture batch culture
- feed process fed batch
- repetitive feed process repeated fed batch process
- a summary of known culture methods is described in the textbook by Chmiel (Bioreatechnik 1. Einbowung in die Biovonstechnik [Bioprocess Technology 1. Introduction to Bioprocess Technology (Gustav Fischer Verlag, Stuttgart, 1991) ) or in the textbook by Storhas (Bioreaktoren und periphere bamboo [Bioreactors and Peripheral Equipment] (Vieweg Verlag, Braunschweig/Wiesbaden, 1994)).
- the culture medium to be used must meet the requirements of the particular microorganisms in a suitable manner. Descriptions of culture media for various microorganisms are contained in the handbook "Manual of Methods for General Bacteriology” of the American Society for Bacteriology (Washington D.C., USA, 1981).
- Sugars and carbohydrates such as e.g. glucose, sucrose, lactose, fructose, maltose, molasses, starch and cellulose, oils and fats, such as e. g. soya oil, sunflower oil, groundnut oil and coconut fat, fatty acids, such as e. g. palmitic acid, stearic acid and linoleic acid, alcohols, such as e. g.
- glycerol and ethanol and organic acids, such as e. g. acetic acid, can be used as the source of carbon.
- organic nitrogen-containing compounds such as peptones, yeast extract, meat extract, malt extract, corn steep liquor, soya bean flour and urea, or inorganic compounds, such as ammonium sulphate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate, can be used as the source of nitrogen.
- the sources of nitrogen can be used individually or as a mixture.
- Potassium dihydrogen phosphate or dipotassiu hydrogen phosphate or the corresponding sodium-containing salts can be used as the source of phosphorus.
- the culture medium must furthermore comprise salts of metals, such as e. g. magnesium sulfate or iron sulfate, which are necessary for growth.
- salts of metals such as e. g. magnesium sulfate or iron sulfate
- essential growth substances such as amino acids and vitamins, can be employed in addition to the above- mentioned substances.
- Suitable precursors can moreover be added to the culture medium.
- the starting substances mentioned can be added to the culture in the form of a single batch, or can be fed in during the culture in a suitable manner.
- Basic compounds such as sodium hydroxide, potassium hydroxide, ammonia, or acid compounds, such as phosphoric acid or sulfuric acid, can be employed in a suitable manner to control the pH.
- Antifoams such as e.g. fatty acid polyglycol esters, can be employed to control the development of foam.
- Suitable substances having a selective action e.g. antibiotics, can be added to the medium to maintain the stability of plasmids.
- oxygen or oxygen-containing gas mixtures such as e.g. air, are introduced into the culture.
- the temperature of the culture is usually 20°C to 45°C, and preferably 25°C to 40°C. Culturing is continued until a maximum of L-amino acid has formed. This target is usually reached within 10 hours to 160 hours.
- L-amino acids can be carried out by anion exchange chromatography with subsequent ninhydrin derivatization, as described by Spackman et al. (Analytical Chemistry, 30, (1958), 1190), or it can take place by reversed phase HPLC as described by Lindroth et al. (Analytical Chemistry (1979) 51:. 1167-1174).
- DSMZ German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
- Tet Resistance gene for tetracycline oriV: Plasmid-coded replication origin of E. coli
- RP4mob mob region for mobilizing the plasmid rep: Plasmid-coded replication origin from
- Tet Resistance gene for tetracycline rep: Plasmid-coded replication origin from
- ColEl ori Replication origin of the plasmid ColEl lacZ: Cloning relict of the lacZ ⁇ gene fragment fl ori: Replication origin of phage fl K R: Kanamycin resistance ApR: Ampicillin resistance poxBin : internal fragment of the poxB gene
- Hindlll Cleavage site of the restriction enzyme
- Hindlll Kpnl Cleavage site of the restriction enzyme Kpnl
- Sp l Cleavage site of the restriction enzyme Sphl
- ⁇ Zap ExpressTM kit was purchased from Stratagene (Stratagene, 11011 North Torrey Pines Rd., La Jolla, California 92037.) and used according to the manufacturers instructions. AS019-DNA was digested with restriction enzyme Sau3A and ligated to BamHI treated and dephosphorylated ⁇ Zap ExpressTM arms.
- Plasmid DNA was isolated from one transformant as according to Birnboim and Doly, 1979, (A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research, 7: 1513-1523.), and designated pTSM2.
- the clone pTSM2 was commercially sequenced by MWG-Biotech Ltd., Waterside House, Peartree Bridge, Milton Keynes MK6 3BY, U.K.
- High purity plasmid DNA was prepared for MWG- Biotech, using the QIAprep Spin Miniprep Kit (QIAGEN GmbH, Max-Volmer-Strasse 4, 40724 Hilden, Germany), and subsequently freeze dried using a Lyovac GT 2 freeze dryer (Leybold Heraeus) .
- Initial sequence analysis was carried out using the universal forward and M13 reverse primers.
- M13/pUC forward primer 5' GTAAAACGACGGCCAGT 3'
- M13/pUC reverse primer 5' CAGGAAACAGCTATGAC 3'
- SEQ ID NO 1 The sequence thus obtained is shown in SEQ ID NO 1.
- the analysis of the nucleotide sequence obtained revealed an open reading frame of 2094 base pairs which was designated as tkt gene. It codes for a protein of 697 amino acids shown in SEQ ID NO 2.
- the E. coli - C. glutamicum shuttle vector pEC-T18mob2 was constructed according to the prior art.
- the vector contains the replication region rep of the plasmid pGAl including the replication effector per (US-A- 5,175,108; Nesvera et al., Journal of Bacteriology 179, 1525-1532 (1997)), the tetracycline resistance-imparting tetA(Z) gene of the plasmid pAGl (US-A- 5,158,891; gene library entry at the National Center for Biotechnology
- NCBI Bethesda, MD, USA
- accession number AF121000 accession number AF121000
- the replication region oriV of the plasmid pMBl (Sutcliffe, Cold Spring Harbor Symposium on Quantitative Biology 43, 77-90 (1979)
- the lacZ ⁇ gene fragment including the lac promoter and a multiple cloning site (mcs) (Norrander et al . Gene 26, 101-106 (1983)) and the mob region of the plasmid RP4 (Simon et al., (1983) Bio/Technology 1:784-791).
- the vector constructed was transformed in the E. coli strain DH5 ⁇ (Hanahan, In: DNA cloning. A practical approach. Vol. I. IRL-Press, Oxford, Washington DC, USA) . Selection for plasmid-carrying cells was made by plating out the transformation batch on LB agar (Sambrook et al., Molecular cloning: a laboratory manual. 2 nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.), which had been supplemented with 5 mg/1 tetracycline. Plasmid DNA was isolated from a transformant with the aid of the QIAprep Spin Miniprep Kit from Qiagen and checked by restriction with the restriction enzymes EcoRI and Hindlll subsequent agarose gel electrophoresis (0.8%).
- DSMZ German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
- PCR was used to amplify DNA fragments containing the entire tkt gene of C. glutamicum and flanking upstream and downstream regions. PCR reactions were carried out using oligonucleotide primers designed from SEQ ID NO 1. Genomic DNA was isolated from Corynebacterium glutamicum ATCC13032 according to Heery and Dunican, (Applied and Environmental Microbiology 59: 791-799 (1993)) and approx. 150-200 ng used as template. The primers used were:
- primer 5' CTG ATC ATC GGA TCT AAC GAA 3' tkt rev. primer: 5' ATT GCC CCG GGT TGA AGC TAA3 3'
- the PCR product obtained was cloned into the commercially available pGEM-T vector purchased from Promega Corp. (pGEM- T Easy Vector System 1, cat. no. A1360, Promega UK, Victoria) using E. coli strain JM109 (Yanisch-Perron et al., Gene 33: 103-119 (1985)) as a host.
- the entire tkt gene was subsequently isolated from the pGEM T-vector on an Sphl/Sall fragment and cloned into the lacZ Sphl/Sall region of the E. coli - C. glutamicum shuttle vector pEC- T18mob2 ( Figure 1), and designated pMS82 ( Figure 2).
- Restriction enzyme analysis with Accl revealed the incorrect orientation of the tkt gene in the lacZ ⁇ gene of pEC-T18mob2. The orientation was corrected by restricting with EcoRI enzyme (Boehringher Mannheim GmbH, Germany) and religating. Restriction enzyme analysis with Accl (Boehringer Mannheim GmbH, Germany) revealed the correct orientation of the tkt gene in the lacZ ⁇ gene (i. e. downstream the lac-Promotor) of pEC- Tl8mob2 and this plasmid was designated the name pMS82B ( Figure 3) .
- the L-lysine-producing strain Corynebacterium glutamicum DSM5715 is described in EP-B-0435132 and the strain DSM12866 is described in DE-A-19931314.8. Both strains are deposited at the Deutsche Sammlung fur Mikroorganismen und Zellkulturen [German Collection of Microorganisms and Cell Cultures] in Braunschweig (Germany) in accordance with the Budapest Treaty.
- the strains DSM5715 and DSM12866 were transformed with the plasmid pMS82B using the electroporation method described by Liebl et al. (FEMS Microbiology Letters, 53:299-303 (1989) ) . Selection of the transformants took place on LBHIS agar comprising 18.5 g/1 brain-heart infusion broth, 0.5 M sorbitol, 5 g/1 Bacto-tryptone, 2.5 g/1 Bacto-yeast extract, 5 g/1 NaCl and 18 g/1 Bacto-agar, which had been supplemented with 5 mg/1 tetracycline. Incubation was carried out for 2 days at 33°C.
- Plasmid DNA was isolated in each case from a transformant by conventional methods (Peters-Wendisch et al., 1998, Microbiology, 144, 915 - 927), cleaved with the restriction endonuclease Accl, and the plasmid was checked by subsequent agarose gel electrophoresis. The strains obtained in this way were called DSM5715/pMS82B and DSM12866/pMS82B.
- the Corynebacterium glutamicum strains DSM5715/pMS82B and DSM12866/pMS82B obtained in Example 4.1 were cultured in a nutrient medium suitable for the production of lysine and the lysine content in the culture supernatant was determined.
- the strain was first incubated on an agar plate with the corresponding antibiotic (brain-heart agar with tetracycline (5 mg/1) ) for 24 hours at 33°C.
- a preculture was seeded (10 ml medium in a 100 ml conical flask) .
- the complete medium Cglll was used as the medium for the preculture.
- Tetracycline (5 mg/1) was added to this.
- the preculture was incubated for 16 hours at 33°C at 240 rpm on a shaking machine.
- a main culture was seeded from this preculture such that the initial OD (660nm) of the main culture was 0.1.
- Medium MM was used for the main culture.
- MOPS morpholinopropanesulfonic 20 g/1 acid
- the CSL, MOPS and the salt solution were brought to pH 7 with aqueous ammonia and autoclaved.
- the sterile substrate and vitamin solutions were then added, as well as the CaC0 3 autoclaved in the dry state.
- Culturing is carried out in a 10 ml volume in a 100 ml conical flask with baffles. Tetracycline (5 mg/1) was added. Culturing was carried out at 33°C and 80% atmospheric humidity.
- the OD was determined at a measurement wavelength of 660 nm with a Biomek 1000 (Beckmann Instruments GmbH, Kunststoff) .
- the amount of lysine formed was determined with an amino acid analyzer from Eppendorf- BioTronik (Hamburg, Germany) by ion exchange chromatography and post-column derivatization with ninhydrin detection.
- the cosmid DNA was then cleaved with the restriction enzyme BamHI (Amersham Pharmacia, Freiburg, Germany, Product Description BamHI, Code no. 27-0868-04) .
- the cosmid DNA treated in this manner was mixed with the treated ATCC13032 DNA and the batch was treated with T4 DNA ligase (Amersham Pharmacia, Freiburg, Germany, Product Description T4-DNA-Ligase, Code no.27-0870-04) .
- the ligation mixture was then packed in phages with the aid of Gigapack II XL Packing Extracts (Stratagene, La Jolla, USA, Product Description Gigapack II XL Packing Extract, Code no. 200217) .
- BamHI Amersham Pharmacia, Freiburg, Germany, Product Description BamHI, Code no. 27-0868-04
- coli strain NM554 (Raleigh et al. 1988, Nucleic Acid Res. 16:1563-1575) the cells were taken up in 10 mM MgS0 and mixed with an aliquot of the phage suspension. The infection and titering of the cosmid library were carried out as described by Sambrook et al. (1989, Molecular Cloning: A laboratory Manual, Cold Spring Harbor), the cells being plated out on LB agar (Lennox, 1955, Virology, 1:190) + 100 ⁇ g/ml ampicillin. After incubation overnight at 37°C, recombinant individual clones were selected.
- the cosmid DNA of an individual colony was isolated with the Qiaprep Spin Miniprep Kit (Product No. 27106, Qiagen, Hilden, Germany) in accordance with the manufacturer's instructions and partly cleaved with the restriction enzyme Sau3AI (Amersham Pharmacia, Freiburg, Germany, Product Description Sau3AI, Product No. 27-0913- 02) .
- the DNA fragments were dephosphorylated with shrimp alkaline phosphatase (Roche Molecular Biochemicals, Mannheim, Germany, Product Description SAP, Product No. 1758250) .
- the cosmid fragments in the size range of 1500 to 2000 bp were isolated with the QiaExII Gel Extraction Kit (Product No. 20021, Qiagen, Hilden, Germany) .
- the DNA of the sequencing vector pZero-1 obtained from Invitrogen (Groningen, Holland, Product Description Zero Background Cloning Kit, Product No. K2500-01) was cleaved with the restriction enzyme BamHI (Amersham Pharmacia, Freiburg, Germany, Product Description BamHI, Product No. 27-0868-04) .
- the ligation of the cosmid fragments in the sequencing vector pZero-1 was carried out as described by Sambrook et al.
- the raw sequence data obtained were then processed using the Staden program package (1986, Nucleic Acids Research, 14:217-231) version 97-0.
- the individual sequences of the pZerol derivatives were assembled to a continuous contig.
- the computer-assisted coding region analysis was prepared with the XNIP program (Staden, 1986, Nucleic Acids Research 14:217-231). Further analyses were carried- out with the "BLAST search programs" (Altschul et al., 1997, Nucleic Acids Research, 25:3389-3402), against the non- redundant databank of the "National Center for Biotechnology Information” (NCBI, Bethesda, MD, USA) .
- the resulting nucleotide sequence is shown in SEQ ID No. 3. Analysis of the nucleotide sequence showed an open reading frame of 1737 base pairs, which was called the poxB gene.
- the poxB gene codes for a polypeptide of 579 amino acids (SEQ ID NO. 4) .
- the primers shown were synthesized by MWG Biotech (Ebersberg, Germany) and the PCR reaction was carried out by the standard PCR method of Innis et al. (PCR protocols. A guide to methods and applications, 1990, Academic Press) with Pwo-Polymerase from Boehringer. With the aid of the polymerase chain reaction, a DNA fragment approx. 0.9 kb in size was isolated, this carrying .an internal fragment of the poxB gene and being shown in SEQ ID No. 5.
- the amplified DNA fragment was ligated with the TOPO TA Cloning Kit from Invitrogen Corporation (Carlsbad, CA, USA; Catalogue Number K4500-01) in the vector pCR2.1-TOPO (Mead at al. (1991) Bio/Technology 9:657-663).
- the E. coli strain DH5 was then electroporated with the ligation batch (Hanahan, In: DNA cloning. A practical approach. Vol. I. IRL-Press, Oxford, Washington DC, USA, 1985) . Selection for plasmid-carrying cells was made by plating out the transformation batch on LB agar (Sambrook et al., Molecular cloning: a laboratory manual. 2 nd Ed.
- Plasmid DNA was isolated from a transformant with the aid of the QIAprep Spin Miniprep Kit from Qiagen and checked by restriction with the restriction enzyme EcoRI and subsequent agarose gel electrophoresis (0.8%). The plasmid was called pCR2. IpoxBint ( Figure 4).
- Plasmid pCR2. IpoxBint has been deposited in the form of the strain Escherichia coli DH5 ⁇ /pCR2. IpoxBint as DSM 13114 at the Deutsche Sammlung fur Mikroorganismen und Zellkulturen (DSMZ German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany) in accordance with the Budapest Treaty.
- the vector pCR2. IpoxBint mentioned in Example 7 was electroporated by the electroporation method of Tauch et al. (FEMS Microbiological Letters, 123:343-347 (1994)) in Corynebacterium glutamicum DSM 5715. Strain DSM 5715 is an AEC-resistant lysine producer. The vector pCR2. IpoxBint cannot replicate independently in DSM5715 and is retained in the cell only if it has integrated into the chromosome of DSM 5715. Selection of clones with pCR2.
- IpoxBint integrated into the chromosome was carried out by plating out the electroporation batch on LB agar (Sambrook et al., Molecular cloning: a laboratory manual. 2 nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.), which had been supplemented with 15 mg/1 kanamycin.
- the poxBint fragment was labelled with the Dig hybridization kit from Boehringer by the method of "The DIG System Users Guide for Filter Hybridization" of Boehringer Mannheim GmbH (Mannheim, Germany, 1993) .
- Chromosomal DNA of a potential integrant was isolated by the method of Eikmanns et al. (Microbiology 140: 1817 - 1828 (1994)) and in each case cleaved with the restriction enzymes Sail, Sad and Hindlll. The fragments formed were separated by agarose gel electrophoresis and hybridized at 68°C with the Dig hybrization kit from Boehringer. The plasmid pCR2. IpoxBint mentioned in Example 9 had been inserted into the chromosome of DSM5715 within the chromosomal poxB gene. The strain was called DSM5715 : : pCR2. IpoxBint .
- IpoxBint was transformed with the plasmid pMS82B using the electroporation method described by Liebl et al. (FEMS Microbiology Letters, 53:299-303 (1989)). Selection of the transformants took place on LBHIS agar comprising 18.5 g/1 brain-heart infusion broth, 0.5 M sorbitol, 5 g/1 Bacto-tryptone, 2.5 g/1 Bacto-yeast extract, 5 g/1 NaCl and 18 g/1 Bacto-agar, which had been supplemented with 5 mg/1 tetracycline and 25 mg/1 kanamycin. Incubation was carried out for 2 days at 33°C.
- Plasmid DNA was isolated in each case from a transformant by conventional methods (Peters-Wendisch et al., 1998, Microbiology 144, 915 -927), cleaved with the restriction endonuclease Accl, and the plasmid was checked by subsequent agarose gel electrophoresis. The strain obtained in this way was called DSM5715:pCR2. IpoxBint/pMS82B.
- the strain was first incubated on an agar plate with the corresponding antibiotic (brain-heart agar with ⁇ tetracycline (5 mg/1) and kanamycin (25 mg/1) ) for 24 hours at 33°C.
- a preculture was seeded (10 ml medium in a 100 ml conical flask) .
- the complete medium Cglll was used as the medium for the preculture.
- Tetracycline (5 mg/1) and kanamycin (25 mg/1) were added to this.
- the preculture was incubated for 16 hours at 33°C at 240 rpm on a shaking machine.
- a main culture was seeded from this preculture such that the initial OD (660nm) of the main culture was 0.1.
- Medium MM was used for the main culture.
- MOPS morpholinopropanesulfonic 20 g/1 acid
- the CSL, MOPS and the salt solution were brought to pH 7 with aqueous ammonia and autoclaved.
- the sterile substrate and vitamin solutions were then added, as well as the CaC0 3 autoclaved in the dry state.
- Culturing is carried out in a 10 ml volume in a 100 ml conical flask with baffles. Tetracycline (5 mg/1) and kanamycin (25 mg/1) were added. Culturing was carried out at 33°C and 80% atmospheric humidity.
- the OD was determined at a measurement wavelength of 660 nm with a Biomek 1000 (Beckmann Instruments GmbH, Kunststoff) .
- the amount of lysine formed was determined with an amino acid analyzer from Eppendorf- BioTronik (Hamburg, Germany) by ion exchange chromatography and post-column derivatization with ninhydrin detection.
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00945875A EP1179084B1 (en) | 2000-03-17 | 2000-07-05 | Process for the fermentative preparation of l-amino acids with amplification of the tkt gene |
SK1619-2001A SK16192001A3 (en) | 2000-03-17 | 2000-07-05 | Process for the fermentative preparation of l-amino acids with amplifications of the tkt gene |
KR1020017014660A KR20010112494A (en) | 2000-03-17 | 2000-07-05 | Process for the fermentative preparation of L-amino acids with amplification of the tkt gene |
AU59822/00A AU5982200A (en) | 2000-03-17 | 2000-07-05 | Process for the fermentative preparation of l-amino acids with amplification of the tkt gene |
CA002374012A CA2374012A1 (en) | 2000-03-17 | 2000-07-05 | Process for the fermentative preparation of l-amino acids with amplification of the tkt gene |
DE60036615T DE60036615T2 (en) | 2000-03-17 | 2000-07-05 | METHOD FOR THE FERMENTATIVE MANUFACTURE OF L-AMINO ACIDS BY REINFORCEMENT OF THE TKT GENE |
MXPA01011495A MXPA01011495A (en) | 2000-03-17 | 2000-07-05 | Process for the fermentative preparation of l amino acids with amplification of the tkt gene. |
BR0010713-1A BR0010713A (en) | 2000-03-17 | 2000-07-05 | Process for the fermentative preparation of l-amino acids with amplification of the tkt gene |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52819600A | 2000-03-17 | 2000-03-17 | |
US09/528,196 | 2000-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001068894A1 true WO2001068894A1 (en) | 2001-09-20 |
Family
ID=24104635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/006305 WO2001068894A1 (en) | 2000-03-17 | 2000-07-05 | Process for the fermentative preparation of l-amino acids with amplification of the tkt gene |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1179084B1 (en) |
KR (1) | KR20010112494A (en) |
CN (1) | CN1350589A (en) |
AT (1) | ATE374831T1 (en) |
AU (1) | AU5982200A (en) |
BR (1) | BR0010713A (en) |
CA (1) | CA2374012A1 (en) |
DE (1) | DE60036615T2 (en) |
MX (1) | MXPA01011495A (en) |
PL (1) | PL358913A1 (en) |
SK (1) | SK16192001A3 (en) |
WO (1) | WO2001068894A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008101850A1 (en) * | 2007-02-19 | 2008-08-28 | Evonik Degussa Gmbh | Method of producing methionine in corynebacteria by over-expressing enzymes of the pentose phosphate pathway |
US8222461B2 (en) | 2006-10-20 | 2012-07-17 | Evonik Degussa Gmbh | Mixed oxide catalysts for catalytic gas phase oxidation |
US20150099281A1 (en) * | 2011-12-21 | 2015-04-09 | Cj Cheiljedang Corporation | Method for producing l-lysine using microorganisms having ability to produce l-lysine |
CN115261294A (en) * | 2021-04-30 | 2022-11-01 | 大象株式会社 | Corynebacterium glutamicum mutant strain having improved L-lysine productivity and method for producing L-lysine using the same |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101335853B1 (en) | 2011-12-01 | 2013-12-02 | 씨제이제일제당 (주) | A microorganism having L-amino acids and riboflavin productivity and a method of producing L-amino acids and riboflavin using the same |
CN113957073B (en) * | 2021-10-19 | 2023-09-01 | 山东寿光巨能金玉米开发有限公司 | Tkt gene promoter mutant and application thereof in L-lysine production |
CN116555137A (en) * | 2022-01-30 | 2023-08-08 | 廊坊梅花生物技术开发有限公司 | Threonine producing strain and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605818A (en) * | 1992-12-03 | 1997-02-25 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing L-tryptophan, L-tyrosine or L-phenylalanine |
US5776736A (en) * | 1992-12-21 | 1998-07-07 | Purdue Research Foundation | Deblocking the common pathway of aromatic amino acid synthesis |
-
2000
- 2000-07-05 BR BR0010713-1A patent/BR0010713A/en not_active Application Discontinuation
- 2000-07-05 EP EP00945875A patent/EP1179084B1/en not_active Expired - Lifetime
- 2000-07-05 AT AT00945875T patent/ATE374831T1/en not_active IP Right Cessation
- 2000-07-05 PL PL00358913A patent/PL358913A1/en not_active Application Discontinuation
- 2000-07-05 WO PCT/EP2000/006305 patent/WO2001068894A1/en active IP Right Grant
- 2000-07-05 KR KR1020017014660A patent/KR20010112494A/en not_active Application Discontinuation
- 2000-07-05 AU AU59822/00A patent/AU5982200A/en not_active Abandoned
- 2000-07-05 CN CN00807474A patent/CN1350589A/en active Pending
- 2000-07-05 MX MXPA01011495A patent/MXPA01011495A/en unknown
- 2000-07-05 SK SK1619-2001A patent/SK16192001A3/en unknown
- 2000-07-05 DE DE60036615T patent/DE60036615T2/en not_active Expired - Lifetime
- 2000-07-05 CA CA002374012A patent/CA2374012A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605818A (en) * | 1992-12-03 | 1997-02-25 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing L-tryptophan, L-tyrosine or L-phenylalanine |
US5776736A (en) * | 1992-12-21 | 1998-07-07 | Purdue Research Foundation | Deblocking the common pathway of aromatic amino acid synthesis |
Non-Patent Citations (3)
Title |
---|
BERNHARD J. EIKMANNS ET AL.: "A family of Corynebacterium glutamicum/Escherichia coli shuttle vectors for cloning, controlled gene expression, and promoter probing", GENE, vol. 102, 1991, AMSTERDAM NL, pages 93 - 98, XP002153371 * |
M. IKEDA ET AL.: "Cloning of the transketolase gene and the effect of its dosage on aromatic amino acid production in Corynebacterium glutamicum", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 51, 1999, pages 201 - 206, XP000960910 * |
MASATO IKEDA ET AL.: "Hyperproduction of Tryptophan by Corynebacterium glutamicum with the modified pentose phosphate pathway", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 65, no. 6, June 1999 (1999-06-01), pages 2497 - 2502, XP002153369 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8222461B2 (en) | 2006-10-20 | 2012-07-17 | Evonik Degussa Gmbh | Mixed oxide catalysts for catalytic gas phase oxidation |
US8772551B2 (en) | 2006-10-20 | 2014-07-08 | Evonik Degussa Gmbh | Mixed oxide catalysts for catalytic gas phase oxidation |
WO2008101850A1 (en) * | 2007-02-19 | 2008-08-28 | Evonik Degussa Gmbh | Method of producing methionine in corynebacteria by over-expressing enzymes of the pentose phosphate pathway |
US20150099281A1 (en) * | 2011-12-21 | 2015-04-09 | Cj Cheiljedang Corporation | Method for producing l-lysine using microorganisms having ability to produce l-lysine |
US9593354B2 (en) * | 2011-12-21 | 2017-03-14 | Cj Cheiljedang Corporation | Method for producing L-lysine using microorganisms having ability to produce L-lysine |
US9938546B2 (en) | 2011-12-21 | 2018-04-10 | Cj Cheiljedang Corporation | Method for producing L-lysine using microorganisms having ability to produce L-lysine |
CN115261294A (en) * | 2021-04-30 | 2022-11-01 | 大象株式会社 | Corynebacterium glutamicum mutant strain having improved L-lysine productivity and method for producing L-lysine using the same |
CN115261294B (en) * | 2021-04-30 | 2024-03-29 | 大象株式会社 | Corynebacterium glutamicum mutant strain having improved L-lysine productivity and method for producing L-lysine using same |
Also Published As
Publication number | Publication date |
---|---|
DE60036615T2 (en) | 2008-06-26 |
EP1179084B1 (en) | 2007-10-03 |
SK16192001A3 (en) | 2002-06-04 |
EP1179084A1 (en) | 2002-02-13 |
MXPA01011495A (en) | 2003-02-27 |
ATE374831T1 (en) | 2007-10-15 |
AU5982200A (en) | 2001-09-24 |
DE60036615D1 (en) | 2007-11-15 |
CN1350589A (en) | 2002-05-22 |
BR0010713A (en) | 2002-02-13 |
KR20010112494A (en) | 2001-12-20 |
PL358913A1 (en) | 2004-08-23 |
CA2374012A1 (en) | 2001-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6420151B1 (en) | Nucleotide sequences which code for the pck gene | |
US20050196848A1 (en) | Process for the fermentative production of L-amino acids by attenuation of the poxB gene | |
WO2001004322A9 (en) | Nucleotide sequences which code for the opca gene | |
US20060014259A9 (en) | Process for the preparation of L-amino acids with amplification of the zwf gene | |
US6872553B2 (en) | Nucleotide sequences which code for the pck gene | |
EP1179073B1 (en) | Process for the fermentative preparation of l-amino acids with amplification of the zwf gene | |
US6921651B2 (en) | Process for the preparation of amino acids by using coryneform bacteria with attenuated 1-phosphofructokinase activity | |
US20030175911A1 (en) | Process for the preparation of L-amino acids with amplification of the zwf gene | |
EP1179076B9 (en) | Process for the fermentative preparation of l-amino acids with amplification of the gnd gene | |
US20050112733A1 (en) | Process for the preparation of L-amino acids with amplification of the zwf gene | |
EP1179084B1 (en) | Process for the fermentative preparation of l-amino acids with amplification of the tkt gene | |
US20060177912A1 (en) | Nucleotide sequences which code for the dep34 gene | |
US20030109014A1 (en) | Process for the fermentative preparation of L-amino acids with amplification of the tkt gene | |
EP1709166A1 (en) | Process for the preparation of l-amino acids with amplification of the zwf gene | |
US7205144B2 (en) | Nucleotide sequences encoding a sensor kinase, citA, from Corynebacterium glutamicum | |
US20020168732A1 (en) | Process for the fermentative preparation of L-amino acids using coryneform bacteria | |
US7101690B2 (en) | Attenuated CCPA1 modified bacterial cell and its use for the preparation of L-amino acids | |
US7202061B2 (en) | Process for the preparation of L-amino acids by attenuating the mikE17 gene | |
US7229802B2 (en) | Nucleotide sequences coding for the MtrA and/or MtrB proteins | |
US7306939B2 (en) | Nucleotide sequences encoding the gpm gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00807474.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA CN HU ID JP KR MX PL RU SK UA ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000945875 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 16192001 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/011495 Country of ref document: MX |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2374012 Country of ref document: CA Ref document number: 2374012 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017014660 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017014660 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2000945875 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017014660 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000945875 Country of ref document: EP |